Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Two companies cited for use of unapproved medical devices

Although unrelated cases, both create worry within the medical community

In separate incidents, two medical device manufacturers are in the spotlight for having doctors use their equipment despite it not having FDA approval.

According to the Associated Press, Medtronics is settling a case with the U.S Justice Department on allegations they paid doctors to an unapproved use of its neuro-stimilation device, which was not approved by the FDA.

They will pay the #2.8 million to settle the allegations.

Not related to the Medtronics case, OtisMed was the subject of a recent New York Times feature that told the story of another medical device that was used during a knee replacement surgery, but was not approved by the FDA.

"As it turned out, the OtisMed Corporation, the maker of the OtisKnee, did not seek clearance from the Food and Drug Administration for its OtisKnee guides before it started selling them," according to the New York Times' article. "When the company did apply for F.D.A. review, its application was rejected because, the agency said, the company failed to show that the product was safe and effective."

According to the article, the company and its former chief executive pleaded guilty in December to "criminal charges of distributing adulterated medical devices."

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report